BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Aspinall EJ, Hawkins G, Fraser A, Hutchinson SJ, Goldberg D. Hepatitis B prevention, diagnosis, treatment and care: a review. Occup Med (Lond). 2011;61:531-540. [PMID: 22114089 DOI: 10.1093/occmed/kqr136] [Cited by in Crossref: 83] [Cited by in F6Publishing: 92] [Article Influence: 8.3] [Reference Citation Analysis]
Number Citing Articles
1 Loh K, Badalyan V. Acute Hepatitis. Principles and Practice of Pediatric Infectious Diseases 2023. [DOI: 10.1016/b978-0-323-75608-2.00059-8] [Reference Citation Analysis]
2 Loh K, Mohan P, Khan MA. Chronic Hepatitis. Principles and Practice of Pediatric Infectious Diseases 2023. [DOI: 10.1016/b978-0-323-75608-2.00060-4] [Reference Citation Analysis]
3 Hassnine AA, Saber MA, Fouad YM, Sarhan H, Elsayed MM, Zaki ZM, Abdelraheem EM, Abdelhalim SM, Elsayed AM. Clinical study on the efficacy of hepatitis B vaccination in hepatitis C virus related chronic liver diseases in Egypt. Virus Research 2022. [DOI: 10.1016/j.virusres.2022.198953] [Reference Citation Analysis]
4 Zhao D, Zhang H, Cao Q, Wang Z, Zhang R. The research of SARIMA model for prediction of hepatitis B in mainland China. Medicine (Baltimore) 2022;101:e29317. [PMID: 35687775 DOI: 10.1097/MD.0000000000029317] [Reference Citation Analysis]
5 Eustis SJ, Roberts J, Veronese N, Trott M, Smith L. Diet, inflammation, and the “itises” (including musculoskeletal and gastrointestinal conditions). Diet, Inflammation, and Health 2022. [DOI: 10.1016/b978-0-12-822130-3.00009-0] [Reference Citation Analysis]
6 Xia J. The significance of locating the source of outbreak efficiently: Epidemiological studies of Hepatitis A. 4TH INTERNATIONAL CONFERENCE ON FRONTIERS OF BIOLOGICAL SCIENCES AND ENGINEERING (FBSE 2021) 2022. [DOI: 10.1063/5.0094303] [Reference Citation Analysis]
7 Akgöllü E. Effect of FOXP3 gene variants on the immune-active HBV and inactive HBV phases. Cukurova Medical Journal 2021;46:1485-1492. [DOI: 10.17826/cumj.978353] [Reference Citation Analysis]
8 Silva Lobato GD, Alves Farias A, da Silva AP, Araújo Júnior JRRD. Drug treatment of chronic hepatitis b in Brazil: a review. GHOA 2021;12:182-185. [DOI: 10.15406/ghoa.2021.12.00483] [Reference Citation Analysis]
9 Watanabe T, Inoue T, Tanaka Y. Hepatitis B Core-Related Antigen and New Therapies for Hepatitis B. Microorganisms 2021;9:2083. [PMID: 34683404 DOI: 10.3390/microorganisms9102083] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
10 Elshayeb AF, Abdrabu MG, Asar SL, Abdelaziz MA, Abuelkheir H. Assessment of hepatitis B virus pregenomic RNA in high and low viremic chronic hepatitis B patients. Clin Exp Hepatol 2021;7:85-92. [PMID: 34027120 DOI: 10.5114/ceh.2021.104472] [Reference Citation Analysis]
11 Alshaer W, Zureigat H, Al Karaki A, Al-Kadash A, Gharaibeh L, Hatmal MM, Aljabali AAA, Awidi A. siRNA: Mechanism of action, challenges, and therapeutic approaches. Eur J Pharmacol 2021;905:174178. [PMID: 34044011 DOI: 10.1016/j.ejphar.2021.174178] [Cited by in Crossref: 24] [Cited by in F6Publishing: 29] [Article Influence: 24.0] [Reference Citation Analysis]
12 Nlankpe AM, Kwadzokpui PK, Adedia D, Nignan JN, Owiafe PK. Seroepidemiology of Hepatitis B and C Virus Infections: A Five-Year Retrospective Study among Blood Donors in Saboba District in the Northern Region of Ghana. Biomed Res Int 2021;2021:5599705. [PMID: 34055986 DOI: 10.1155/2021/5599705] [Reference Citation Analysis]
13 Hamida ME, Raja SM, Seyoum Y, Elkhidir IM, Tekle F. Prevalence of chronic hepatitis B phases in Eritrean patients: a laboratory-based cross-sectional study. BMC Gastroenterol 2021;21:198. [PMID: 33933017 DOI: 10.1186/s12876-021-01789-3] [Reference Citation Analysis]
14 Khatami A, Bahadory S, Ghorbani S, Saadati H, Zarei M, Soleimani A, Zibaei M. Two rivals or colleagues in the liver? Hepatit B virus and Schistosoma mansoni co-infections: A systematic review and meta-analysis. Microb Pathog 2021;154:104828. [PMID: 33744336 DOI: 10.1016/j.micpath.2021.104828] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
15 Kiliçaslan Ö, Sav NM, Erişen Karaca S, Sungur MA, Öztürk C, Kocabay K. Adolesan Çocuklarda Hepatit B Belirteçlerinin İncelenmesi-Düzce Üniversitesi Hastanesi 5 Yıllık Sonuçlar. Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi. [DOI: 10.33631/duzcesbed.824589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Ehtesabi H. Application of carbon nanomaterials in human virus detection. Journal of Science: Advanced Materials and Devices 2020;5:436-50. [DOI: 10.1016/j.jsamd.2020.09.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
17 Aluora PO, Muturi MW, Gachara G. Seroprevalence and genotypic characterization of HBV among low risk voluntary blood donors in Nairobi, Kenya. Virol J 2020;17:176. [PMID: 33187530 DOI: 10.1186/s12985-020-01447-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Chilaka VN, Hassan R, Konje JC. Post-exposure prophylaxis for Blood-Borne Viral (BBV) Infections. Eur J Obstet Gynecol Reprod Biol 2020;255:83-91. [PMID: 33113403 DOI: 10.1016/j.ejogrb.2020.10.032] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Li Y, Li S, Duan X, Yang C, Xu M, Chen L. Macrophage Phenotypes and Hepatitis B Virus Infection. J Clin Transl Hepatol. 2020;8:424-431. [PMID: 33447526 DOI: 10.14218/jcth.2020.00046] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
20 Sadighbayan D, Hasanzadeh M, Ghafar-Zadeh E. Biosensing based on field-effect transistors (FET): Recent progress and challenges. Trends Analyt Chem 2020;133:116067. [PMID: 33052154 DOI: 10.1016/j.trac.2020.116067] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 30.0] [Reference Citation Analysis]
21 Hashemi SMA, Department of Bacteriology and Virology, Shiraz University of Medical Sciences, Shiraz, Iran, Hashemzadeh F, Bahrampour H, Nekoei F, Joharinia N, Sarvari J, Department of Microbiology, Golestan University of Medical Sciences, Gorgan, Iran, Department of Bacteriology and Virology, Shiraz University of Medical Sciences, Shiraz, Iran, Department of Bacteriology and Virology, Shiraz University of Medical Sciences, Shiraz, Iran, Department of Bacteriology and Virology, Shiraz University of Medical Sciences, Shiraz, Iran, Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. The evaluation anti-HBsAb titer among university students in Shiraz, 2019. Iran J Med Microbiol 2020;14:297-306. [DOI: 10.30699/ijmm.14.4.297] [Reference Citation Analysis]
22 Cao W, Cao N, Gu M, Li P, Li M, Luo C, Liu H, Jiang F, Li C, Cao S. Prevalence of Percutaneous Injuries and Associated Factors Among a Sample of Midwives in Hunan Province, China. Workplace Health Saf 2020;68:422-31. [PMID: 32469688 DOI: 10.1177/2165079920914923] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
23 Hoffman M, Chigbu DI, Crumley BL, Sharma R, Pustylnikov S, Crilley T, Ginwala R, Loonawat R, Joseph J, Sales D, Wilson S, Jain P. Human Acute and Chronic Viruses: Host-Pathogen Interactions and Therapeutics. Advanced Concepts in Human Immunology: Prospects for Disease Control 2020. [DOI: 10.1007/978-3-030-33946-3_1] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Sali S, Nasiri M. Tenofovir Response Rate and Adverse Effects in Patients with Chronic Hepatitis B Attending to Hepatitis Clinic at Labbafinejad Hospital. Jundishapur J Nat Pharm Prod 2019;14. [DOI: 10.5812/jjnpp.63023] [Reference Citation Analysis]
25 Nguyen ATL, Le XTT, Do TTT, Nguyen CT, Hoang Nguyen L, Tran BX, Le HT. Knowledge, Preference, and Willingness to Pay for Hepatitis B Vaccination Services among Woman of Reproductive Age in Vietnam. Biomed Res Int 2019;2019:9154918. [PMID: 30915364 DOI: 10.1155/2019/9154918] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Huang W, Skanderup AJ, Lee CG. Advances in genomic hepatocellular carcinoma research. Gigascience. 2018;7. [PMID: 30521023 DOI: 10.1093/gigascience/giy135] [Cited by in Crossref: 13] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
27 Batsis ID, Wasuwanich P, Karnsakul WW. The management of hepatitis B and hepatitis C in children. Minerva Pediatr 2019;71:59-75. [PMID: 30334626 DOI: 10.23736/S0026-4946.18.05410-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
28 Dobrica MO, Lazar C, Paruch L, van Eerde A, Clarke JL, Tucureanu C, Caras I, Ciulean S, Onu A, Tofan V, Branzan A, Urban S, Stavaru C, Branza-Nichita N. Oral administration of a chimeric Hepatitis B Virus S/preS1 antigen produced in lettuce triggers infection neutralizing antibodies in mice. Vaccine 2018;36:5789-95. [PMID: 30082163 DOI: 10.1016/j.vaccine.2018.07.072] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
29 Gao X, Zhao P, Hu J, Zhu H, Zhang J, Zhou Z, Zhao J, Tang F. MicroRNA-194 protects against chronic hepatitis B-related liver damage by promoting hepatocyte growth via ACVR2B. J Cell Mol Med 2018;22:4534-44. [PMID: 30044042 DOI: 10.1111/jcmm.13714] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
30 Kotha S, Neong S, Patel K. Serum biomarkers for diagnosis and monitoring viral hepatitis and hepatocellular carcinoma. Expert Rev Mol Diagn 2018;18:713-22. [PMID: 30019978 DOI: 10.1080/14737159.2018.1496020] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
31 Thilakanathan C, Wark G, Maley M, Davison S, Lawler J, Lee A, Shackel N, Nguyen V, Jackson K, Glass A, Locarnini SA, Levy MT. Mother-to-child transmission of hepatitis B: Examining viral cut-offs, maternal HBsAg serology and infant testing. Liver Int 2018;38:1212-9. [PMID: 29532580 DOI: 10.1111/liv.13736] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
32 Bangalore Kumar A, Maus R, Markovic SN. Pharmacologic Modulation of Human Immunity in the Era of Immuno-oncology: Something Old, Something New. Mayo Clinic Proceedings 2018;93:917-36. [DOI: 10.1016/j.mayocp.2018.03.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
33 Wright CM, Boudarène L, Ha NT, Wu O, Hawkins N. A systematic review of hepatitis B screening economic evaluations in low- and middle-income countries. BMC Public Health 2018;18:373. [PMID: 29558894 DOI: 10.1186/s12889-018-5261-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
34 Annisa, Zain L, Loesnihari R. Protection status against hepatitis B infection assessed fromanti-HBs level, history of vaccination andhistory of infection based on anti-HBc in medical students. IOP Conf Ser : Earth Environ Sci 2018;125:012104. [DOI: 10.1088/1755-1315/125/1/012104] [Reference Citation Analysis]
35 Tian H, He Z. miR-200c targets nuclear factor IA to suppress HBV replication and gene expression via repressing HBV Enhancer I activity. Biomed Pharmacother 2018;99:774-80. [PMID: 29710475 DOI: 10.1016/j.biopha.2018.01.141] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
36 James WH, Grech V. Can sex ratios at birth be used in the assessment of public health, and in the identification of causes of selected pathologies? Early Hum Dev 2018;118:15-21. [PMID: 29428574 DOI: 10.1016/j.earlhumdev.2018.02.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
37 Badalyan V, Conklin LS, Snyder JD. Acute Hepatitis. Principles and Practice of Pediatric Infectious Diseases 2018. [DOI: 10.1016/b978-0-323-40181-4.00060-8] [Reference Citation Analysis]
38 Mohan P, Khan MA, Snyder JD. Chronic Hepatitis. Principles and Practice of Pediatric Infectious Diseases 2018. [DOI: 10.1016/b978-0-323-40181-4.00061-x] [Reference Citation Analysis]
39 Gupta SP. Viral Hepatitis. Studies on Hepatitis Viruses 2018. [DOI: 10.1016/b978-0-12-813330-9.00001-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
40 Ničković V, Katanić R, Katanić N, Kocić I. CHRONIC HEPATITIS B. amm 2017;56:50-60. [DOI: 10.5633/amm.2017.0408] [Reference Citation Analysis]
41 Kaweti G, Abegaz T. Magnitude of splash exposure and associated factors among health care workers in Hawassa referral and Adare District hospitals, January 2014. Ann of Occup and Environ Med 2017;29. [DOI: 10.1186/s40557-017-0188-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
42 Mavandadnejad F, Yazdi MH, Hassanzadeh SM, Mahdavi M, Faramarzi MA, Pazoki‐toroudi H, Shahverdi AR. Biosynthesis of SeNPs by Mycobacterium bovis and their enhancing effect on the immune response against HBs antigens: an in vivo study. IET nanobiotechnol 2018;12:57-63. [DOI: 10.1049/iet-nbt.2017.0006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
43 Fattahi S, Karimi Alivije M, Babamahmoodi F, Bayani M, Sadeghi Haddad Zavareh M, Asouri M, Lotfi M, Amirbozorgi G, Akhavan-Niaki H. Cytochrome P450 Genes (CYP2E1 and CYP1A1) Variants and Susceptibility to Chronic Hepatitis B Virus Infection. Indian J Clin Biochem 2018;33:467-72. [PMID: 30319195 DOI: 10.1007/s12291-017-0698-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
44 Mukhtar NA, Kathpalia P, Hilton JF, Lau G, Yu A, Grumbach K, Nguyen TT, Chan D, Khalili M. Provider, Patient, and Practice Factors Shape Hepatitis B Prevention and Management by Primary Care Providers. J Clin Gastroenterol 2017;51:626-31. [PMID: 27811627 DOI: 10.1097/MCG.0000000000000738] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 4.6] [Reference Citation Analysis]
45 Cheng W, Ji M, Li X, Ren J, Yin F, van Ofwegen L, Yu S, Chen X, Lin W. Fragilolides A-Q, norditerpenoid and briarane diterpenoids from the gorgonian coral Junceella fragilis. Tetrahedron 2017;73:2518-28. [DOI: 10.1016/j.tet.2017.03.037] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
46 Twagirumugabe T, Swaibu G, Walker TD, Lindh M, Gahutu JB, Bergström T, Norder H. Hepatitis B virus strains from Rwandan blood donors are genetically similar and form one clade within subgenotype A1. BMC Infect Dis 2017;17:32. [PMID: 28056881 DOI: 10.1186/s12879-016-2149-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
47 Mirian M, Khanahmad H, Darzi L, Salehi M, Sadeghi-Aliabadi H. Oligonucleotide aptamers: potential novel molecules against viral hepatitis. Res Pharm Sci 2017;12:88-98. [PMID: 28515761 DOI: 10.4103/1735-5362.202447] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
48 Lin S, Su T, Chu C, Chang Y, Yang L, Kuo Y, Huang T. Synthesis of C-4-Substituted Steviol Derivatives and Their Inhibitory Effects against Hepatitis B Virus. J Nat Prod 2016;79:3057-64. [DOI: 10.1021/acs.jnatprod.6b00671] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
49 Alanko Blomé M, Björkman P, Flamholc L, Jacobsson H, Widell A. Vaccination against hepatitis B virus among people who inject drugs - A 20year experience from a Swedish needle exchange program. Vaccine 2017;35:84-90. [PMID: 27894721 DOI: 10.1016/j.vaccine.2016.11.041] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
50 Inoue T, Tanaka Y. Hepatitis B virus and its sexually transmitted infection - an update. Microb Cell 2016;3:420-37. [PMID: 28357379 DOI: 10.15698/mic2016.09.527] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 9.2] [Reference Citation Analysis]
51 Shen ML, Xu HT, Ju HF, Xian JC, Yang XZ. Sequential telbivudine/lamivudine and hepatitis B immunoglobulin therapy for preventing mother-to-infant transmission of hepatitis B virus. Shijie Huaren Xiaohua Zazhi 2016; 24(23): 3517-3522 [DOI: 10.11569/wcjd.v24.i23.3517] [Reference Citation Analysis]
52 Pfaender S, von Hahn T, Steinmann J, Ciesek S, Steinmann E. Prevention strategies for blood-borne viruses-in the Era of vaccines, direct acting antivirals and antiretroviral therapy. Rev Med Virol 2016;26:330-9. [PMID: 27185010 DOI: 10.1002/rmv.1890] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
53 Du J, Xu Y, Wang J, Liu S, Liu Y, Zhang X, Xu E. 24 year outcomes of hepatitis B vaccination in Hangzhou, China. Hum Vaccin Immunother 2015;11:2051-60. [PMID: 25714188 DOI: 10.1080/21645515.2015.1008873] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
54 Kaweti G, Abegaz T. Prevalence of percutaneous injuries and associated factors among health care workers in Hawassa referral and adare District hospitals, Hawassa, Ethiopia, January 2014. BMC Public Health 2016;16:8. [PMID: 26729189 DOI: 10.1186/s12889-015-2642-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
55 Syn G, Blackwell JM, Jamieson SE. Epigenetics in Infectious Diseases. Epigenetic Biomarkers and Diagnostics 2016. [DOI: 10.1016/b978-0-12-801899-6.00019-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
56 Liang TJ, Block TM, McMahon BJ, Ghany MG, Urban S, Guo JT, Locarnini S, Zoulim F, Chang KM, Lok AS. Present and future therapies of hepatitis B: From discovery to cure. Hepatology 2015;62:1893-908. [PMID: 26239691 DOI: 10.1002/hep.28025] [Cited by in Crossref: 221] [Cited by in F6Publishing: 202] [Article Influence: 31.6] [Reference Citation Analysis]
57 Wu Y, Jie Y, Li X, Huang M, Li X, Shi H, Chen S, Zhang M, Ao Y, Yang F, Gao Z, Lin G, Chong Y. Comprehensive analysis of hospital-based prospective cohort reveals the unique effectiveness and safety for nucleos(t)ide analogues in HBV patients. Clin Res Hepatol Gastroenterol 2016;40:213-20. [PMID: 26598028 DOI: 10.1016/j.clinre.2015.06.018] [Reference Citation Analysis]
58 Ozaras R, Corti G, Ruta S, Lacombe K, Mondelli M, Irwing W, Puoti M, Khalighi A, Santos M, Harxhi A, Lazarevic I, Soriano V, Gervain J, Leblebicioglu H, Salmon D, Arends J. Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe. Clinical Microbiology and Infection 2015;21:1027-32. [DOI: 10.1016/j.cmi.2015.07.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
59 Unnewehr M, Stich A. Fighting Hepatitis B in North Korea: Feasibility of a Bi-modal Prevention Strategy. J Korean Med Sci 2015;30:1584-8. [PMID: 26539001 DOI: 10.3346/jkms.2015.30.11.1584] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
60 Mueller A, Stoetter L, Kalluvya S, Stich A, Majinge C, Weissbrich B, Kasang C. Prevalence of hepatitis B virus infection among health care workers in a tertiary hospital in Tanzania. BMC Infect Dis 2015;15:386. [PMID: 26399765 DOI: 10.1186/s12879-015-1129-z] [Cited by in Crossref: 47] [Cited by in F6Publishing: 55] [Article Influence: 6.7] [Reference Citation Analysis]
61 Toita R, Kawano T, Kang JH, Murata M. Applications of human hepatitis B virus preS domain in bio- and nanotechnology. World J Gastroenterol 2015; 21(24): 7400-7411 [PMID: 26139986 DOI: 10.3748/wjg.v21.i24.7400] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
62 Block TM, Rawat S, Brosgart CL. Chronic hepatitis B: A wave of new therapies on the horizon. Antiviral Res. 2015;121:69-81. [PMID: 26112647 DOI: 10.1016/j.antiviral.2015.06.014] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 7.4] [Reference Citation Analysis]
63 Dong H, Zhang L, Qian Z, Zhu X, Zhu G, Chen Y, Xie X, Ye Q, Zang J, Ren Z, Ji Q. Identification of HBV-MLL4 Integration and Its Molecular Basis in Chinese Hepatocellular Carcinoma. PLoS One. 2015;10:e0123175. [PMID: 25901726 DOI: 10.1371/journal.pone.0123175] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 5.7] [Reference Citation Analysis]
64 Tsukakoshi T, Samuela J, Rafai EV, Rabuatoka U, Honda S, Kamiya Y, Buerano CC, Morita K. Hepatitis B serologic survey and review of immunization records of children, adolescents and adults in Fiji, 2008-2009. Virol J 2015;12:36. [PMID: 25890269 DOI: 10.1186/s12985-015-0267-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
65 Gasim GI, Bella A, Adam I. Immune response to hepatitis B vaccine among patients on hemodialysis. World J Hepatol 2015; 7(2): 270-275 [PMID: 25729482 DOI: 10.4254/wjh.v7.i2.270] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
66 Dai K, Huang L, Chen J, Yang L, Gong Z. Amphiregulin promotes the immunosuppressive activity of intrahepatic CD4+ regulatory T cells to impair CD8+ T-cell immunity against hepatitis B virus infection. Immunology 2015;144:506-17. [PMID: 25298208 DOI: 10.1111/imm.12400] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
67 Qu J, Yu Z, Li Q, Chen Y, Xiang D, Tan L, Lei C, Bai W, Li H, Shang Q, Chen L, Hu X, Lu W, Li Z, Chen D, Wang X, Zhang C, Xiao G, Qi X, Chen J, Zhou L, Chen G, Li Y, Zeng Z, Rong G, Dong Z, Chen Y, Lou M, Wang C, Lu Y, Zhang C, Yang Y. Blocking and reversing hepatic fibrosis in patients with chronic hepatitis B treated by traditional Chinese medicine (tablets of biejia ruangan or RGT): study protocol for a randomized controlled trial. Trials. 2014;15:438. [PMID: 25381721 DOI: 10.1186/1745-6215-15-438] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
68 Mankal PK, Abed J, Aristy JD, Munot K, Suneja U, Engelson ES, Kotler DP. Relative effects of heavy alcohol use and hepatitis C in decompensated chronic liver disease in a hospital inpatient population. Am J Drug Alcohol Abuse 2015;41:177-82. [PMID: 25320839 DOI: 10.3109/00952990.2014.964358] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
69 Phillips AC, Carroll D, Drayson MT, Batty GD. Raised levels of immunoglobulin G, A and M are associated with an increased risk of total and cause-specific mortality: the Vietnam Experience Study. J Epidemiol Community Health 2015;69:129-35. [PMID: 25267764 DOI: 10.1136/jech-2014-204345] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
70 Ahn SS, Chon YE, Kim BK, Kim SU, Kim DY, Ahn SH, Han KH, Park JY. Tenofovir disoproxil fumarate monotherapy for nucleos(t)ide-naïve chronic hepatitis B patients in Korea: data from the clinical practice setting in a single-center cohort. Clin Mol Hepatol 2014;20:261-6. [PMID: 25320729 DOI: 10.3350/cmh.2014.20.3.261] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
71 Gupta N, Goyal M, Wu CH, Wu GY. The Molecular and Structural Basis of HBV-resistance to Nucleos(t)ide Analogs. J Clin Transl Hepatol. 2014;2:202-211. [PMID: 26357626 DOI: 10.14218/jcth.2014.00021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
72 Carmo RA, Melo APS, Dezanet LNC, de Oliveira HN, Cournos F, Guimarães MDC. Correlates of hepatitis B among patients with mental illness in Brazil. General Hospital Psychiatry 2014;36:398-405. [DOI: 10.1016/j.genhosppsych.2014.03.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
73 Ma WL, Lai HC, Yeh S, Cai X, Chang C. Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis. Endocr Relat Cancer 2014;21:R165-82. [PMID: 24424503 DOI: 10.1530/ERC-13-0283] [Cited by in Crossref: 99] [Cited by in F6Publishing: 105] [Article Influence: 12.4] [Reference Citation Analysis]
74 Duygu F, Aksoy N, Cicek AC, Butun I, Unlu S. Does prolidase indicate worsening of hepatitis B infection? J Clin Lab Anal. 2013;27:398-401. [PMID: 24038226 DOI: 10.1002/jcla.21617] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
75 McLellan AT. Should at-risk patients be paid to receive interventions? Lancet 2014;384:113-4. [PMID: 24725466 DOI: 10.1016/S0140-6736(14)60490-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
76 Pittman C, Plitt S, Birse T, Doucette K, Romanowski B, Cooper R, Houston S, Shafran S, Singh AE. Prevalence and correlates of HIV and hepatitis B virus coinfection in Northern Alberta. Can J Infect Dis Med Microbiol 2014;25:e8-e13. [PMID: 24634693 DOI: 10.1155/2014/971546] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
77 Rezaee-Zavareh MS, Einollahi B. Hepatitis B vaccination: needs a revision. Hepat Mon 2014;14:e17461. [PMID: 24734095 DOI: 10.5812/hepatmon.17461] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
78 Lu T, Seto WK, Zhu RX, Lai CL, Yuen MF. Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection. World J Gastroenterol 2013; 19(47): 8887-8894 [PMID: 24379612 DOI: 10.3748/wjg.v19.i47.8887] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
79 Huang Q, Huang R, Wei L, Chen Y, Lv S, Liang C, Zhang X, Yin F, Li H, Zhuo L. Antiviral activity of methyl helicterate isolated from Helicteres angustifolia (Sterculiaceae) against hepatitis B virus. Antiviral Res. 2013;100:373-381. [PMID: 24055834 DOI: 10.1016/j.antiviral.2013.09.007] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
80 Inoue H, Motani-Saitoh H, Sakurada K, Ikegaya H, Yajima D, Nagasawa S, Iwase H. Genotypic polymorphisms of hepatitis B virus provide useful information for estimating geographical origin or place of long-term residence of unidentified cadavers. J Forensic Sci 2014;59:236-41. [PMID: 24020429 DOI: 10.1111/1556-4029.12257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
81 Schmidt J, Blum HE, Thimme R. T-cell responses in hepatitis B and C virus infection: similarities and differences. Emerg Microbes Infect 2013;2:e15. [PMID: 26038456 DOI: 10.1038/emi.2013.14] [Cited by in Crossref: 48] [Cited by in F6Publishing: 58] [Article Influence: 5.3] [Reference Citation Analysis]
82 de Paula Scalioni L, Cruz HM, de Paula VS, Corrêia Oliveira J, Tourinho Dos Santos R, Motta-Castro AR, Murat PG, Villela-Nogueira CA, Lewis-Ximenez LL, Lampe E, Villar LM. Importance of collection methods and stability of oral fluid samples for hepatitis B surface antigen detection. J Clin Lab Anal 2013;27:186-94. [PMID: 23440736 DOI: 10.1002/jcla.21582] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
83 Wang G, Leng Y, Dou H, Wang L, Li W, Wang X, Sun K, Shen L, Yuan X, Li J, Sun K, Han J, Xiao H, Li Y. Highly efficient preparation of multiscaled quantum dot barcodes for multiplexed hepatitis B detection. ACS Nano 2013;7:471-81. [PMID: 23205725 DOI: 10.1021/nn3045215] [Cited by in Crossref: 75] [Cited by in F6Publishing: 78] [Article Influence: 8.3] [Reference Citation Analysis]
84 Shi H, Lu L, Zhang NP, Zhang SC, Shen XZ. Effect of interferon-γ and tumor necrosis factor-α on hepatitis B virus following lamivudine treatment. World J Gastroenterol 2012; 18(27): 3617-3622 [PMID: 22826629 DOI: 10.3748/wjg.v18.i27.3617] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]